- February 16, 2017 – Gregory S. Korbutt, PhD, Professor of Surgery, University of Alberta, Alberta Diabetes Institute
- March 16, 2017 –Brian N. Finck, PhD – Associate Professor, Internal Medicine, Division of Geriatrics & Nutritional Science, Molecular Cell Biology Program, Washington University in St. Louis, MO - “Standing on the shoulders of giants to study intermediary metabolism”
- April 20, 2017 – Samuel Klein, MD, William H. Danforth Professor of Medicine and Nutritional Science, Director, Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO - “Metabolically normal and abnormal obesity”
- May 18, 2017 – Donald A. McClain, MD, PhD, Director, Center on Diabetes, Obesity, and Metabolism, Professor, Endocrinology and Metabolism, Hypertension and Vascular Research Center, Center on Diabetes, Obesity, and Metabolism, Wake Forest School of Medicine, Winston-Salem - “Iron as a Cofactor in Metabolic Disease”
- September 21, 2017 - Stephen M. Secor, PhD, Professor, Department of Biological Sciences, University of Alabama, Tuscaloosa, AL -“Leveraging the extreme physiology of the Burmese python to decipher the mechanisms of tissue remodeling”
- October 19, 2017 – Andrew A. Butler, PhD, Professor, Department of Pharmacology and Physiology, St. Louis University School of Medicine, St. Louis, MO - “Adropin – a possible link between cholesterol metabolism and glucose control”
- November 16, 2017 - Shawn C. Burgess, PhD, Associate Professor, Center for Human Nutrition and Dept. of Pharmacology, UT Southwestern Medical Center - “Fire and Ice: Mitochondrial Metabolism as a Mediator of Fatty Liver Disease”
- December 14, 2017 - Ralph A. DeFronzo, MD, Chief, Diabetes Division, Deputy Director Texas Diabetes Institute, University of Texas Health Sciences Center, San Antonio, TX – “(1) Pathogenesis of T2DM: The Ominous Octet & More and (2) Treatment of T2DM: A Sound Approach Based Upon Its Pathophysiology”
